临床肿瘤学杂志
臨床腫瘤學雜誌
림상종류학잡지
CHINESE CLINICAL ONCOLOGY
2014年
2期
145-148
,共4页
徐周敏%刘莉娜%裴峰%秦士新%吴俊兰
徐週敏%劉莉娜%裴峰%秦士新%吳俊蘭
서주민%류리나%배봉%진사신%오준란
LRP15基因%胃癌%组织芯片
LRP15基因%胃癌%組織芯片
LRP15기인%위암%조직심편
LRP15 gene%Gastric cancer%Tissue microarray
目的:探讨LRP15基因在胃癌中的表达及其与临床病理特征和预后的关系。方法采用组织芯片技术和免疫组织化学法检测例胃癌组织及对应癌旁组织中LRP15的表达情况,Kaplan-Meier法进行生存分析, Cox模型评估影响预后的因素。结果胃癌组织和癌旁组织中LRP15的表达存在显著性差异(0.563±0.046 vs.0.822±0.054,P<0.001)。按照胃癌组织和癌旁组织LRP15的比值,将例患者分为高表达组(比值≥0.5,n=51)和低表达组(比值<0.5,n=39)。 LRP15的表达与肿块大小( P=0.038)、淋巴结转移( P=0.005)有关,与性别、年龄、肿瘤位置、分化程度、大体分型、TNM分期和浸润深度无关( P>0.05)。高表达者的中位总生存时间为.3个月,高于低表达者的.6个月( P=0.040)。 Cox模型分析显示,癌组织中LRP15的相对表达量、癌组织与癌旁组织LRP15表达量的比值、淋巴结转移和浸润深度均是影响预后的独立因素。结论 LRP15可能在胃癌生长和淋巴结转移中发挥重要作用,有望成为胃癌预后预测的标志物及靶向治疗的新靶点。
目的:探討LRP15基因在胃癌中的錶達及其與臨床病理特徵和預後的關繫。方法採用組織芯片技術和免疫組織化學法檢測例胃癌組織及對應癌徬組織中LRP15的錶達情況,Kaplan-Meier法進行生存分析, Cox模型評估影響預後的因素。結果胃癌組織和癌徬組織中LRP15的錶達存在顯著性差異(0.563±0.046 vs.0.822±0.054,P<0.001)。按照胃癌組織和癌徬組織LRP15的比值,將例患者分為高錶達組(比值≥0.5,n=51)和低錶達組(比值<0.5,n=39)。 LRP15的錶達與腫塊大小( P=0.038)、淋巴結轉移( P=0.005)有關,與性彆、年齡、腫瘤位置、分化程度、大體分型、TNM分期和浸潤深度無關( P>0.05)。高錶達者的中位總生存時間為.3箇月,高于低錶達者的.6箇月( P=0.040)。 Cox模型分析顯示,癌組織中LRP15的相對錶達量、癌組織與癌徬組織LRP15錶達量的比值、淋巴結轉移和浸潤深度均是影響預後的獨立因素。結論 LRP15可能在胃癌生長和淋巴結轉移中髮揮重要作用,有望成為胃癌預後預測的標誌物及靶嚮治療的新靶點。
목적:탐토LRP15기인재위암중적표체급기여림상병리특정화예후적관계。방법채용조직심편기술화면역조직화학법검측례위암조직급대응암방조직중LRP15적표체정황,Kaplan-Meier법진행생존분석, Cox모형평고영향예후적인소。결과위암조직화암방조직중LRP15적표체존재현저성차이(0.563±0.046 vs.0.822±0.054,P<0.001)。안조위암조직화암방조직LRP15적비치,장례환자분위고표체조(비치≥0.5,n=51)화저표체조(비치<0.5,n=39)。 LRP15적표체여종괴대소( P=0.038)、림파결전이( P=0.005)유관,여성별、년령、종류위치、분화정도、대체분형、TNM분기화침윤심도무관( P>0.05)。고표체자적중위총생존시간위.3개월,고우저표체자적.6개월( P=0.040)。 Cox모형분석현시,암조직중LRP15적상대표체량、암조직여암방조직LRP15표체량적비치、림파결전이화침윤심도균시영향예후적독립인소。결론 LRP15가능재위암생장화림파결전이중발휘중요작용,유망성위위암예후예측적표지물급파향치료적신파점。
Objective To investigate the expression of LRP15 gene in gastric cancer and its relationship with clinical features and prognosis. Methods The expression of LRP15 gene was detected using immunohistochemistry in tissue microarrays containing 90 specimens of gastric cancer and paired adjacent normal mucosa tissues. Survival curves were plotted using Kaplan-Meier method, and Cox regression model to evaluate the independent prognostic factors. Results The LRP15 expression was lower in the tumor tissue compared with that in the adjacent normal mucosa tissue (0.563±0.046 vs. 0.822±0.054, P<0.001). According to the ratio of the expression of LRP15 in cancer tissues and that in adjacent tissues were divided into two groups:high-expression group ( ratio≥0.5, n=51) and low-expression group ( ratio<0.5, n=39) . LRP15 expression was statistically correlated with the tumor size ( P=0.038) and lymph node metastasis ( P=0.003) , but not with gender, age, tumor location, differentiation, tumor location, gross type, TNM stage and depth of invasion. The Kaplan-Meier method showed that patients with LRP15 low-expression had a significantly shorter medi-an overall survival compared with the patients with high-expression (27.6 vs 37.3 months, P=0.040). Cox multivariate analysis re-vealed that the expression of LRP15 in cancer tissue,ratio of expression between cancer tissue and adjacent normal mucosa tissues, lymph node metastasis and depth of invasion were both independent prognostic factors. Conclusion LRP15 expression may have an important function in cell growth and is significantly associated with lymph node metastasis. LRP15 can be considered as biomarkers of prognosis and as a new target for gastric cancer therapy.